These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14627985)

  • 1. Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity.
    Del Bufalo D; Trisciuoglio D; Scarsella M; Zangemeister-Wittke U; Zupi G
    Oncogene; 2003 Nov; 22(52):8441-7. PubMed ID: 14627985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
    Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
    Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
    Zhang H; Taylor J; Luther D; Johnston J; Murray S; Wyatt JR; Watt AT; Koo S; York-DeFalco C; Stecker K; Dean NM
    J Pharmacol Exp Ther; 2003 Oct; 307(1):24-33. PubMed ID: 12893848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
    Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I
    Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
    Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
    Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review).
    Kim R; Tanabe K; Emi M; Uchida Y; Toge T
    Int J Oncol; 2004 Jan; 24(1):5-17. PubMed ID: 14654935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of bcl-xl antisense oligodeoxynucleotides on growth of human nasopharyngeal carcinoma in nude mice].
    Min L; Zhou KY; Liang T; Zhang YF
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):14-7. PubMed ID: 15059344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro.
    Benimetskaya L; Ayyanar K; Kornblum N; Castanotto D; Rossi J; Wu S; Lai J; Brown BD; Popova N; Miller P; McMicken H; Chen Y; Stein CA
    Clin Cancer Res; 2006 Aug; 12(16):4940-8. PubMed ID: 16914583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent in vivo antiangiogenic effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an antisense oligonucleotide preventing the expression of insulin receptor substrate-1.
    Al-Mahmood S; Colin S; Farhat N; Thorin E; Steverlynck C; Chemtob S
    J Pharmacol Exp Ther; 2009 May; 329(2):496-504. PubMed ID: 19208899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
    Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
    Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.
    He R; Liu B; Yang C; Yang RC; Tobelem G; Han ZC
    Cancer Gene Ther; 2003 Dec; 10(12):879-86. PubMed ID: 14712314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages.
    Olie RA; Hafner C; Küttel R; Sigrist B; Willers J; Dummer R; Hall J; Stahel RA; Zangemeister-Wittke U
    J Invest Dermatol; 2002 Mar; 118(3):505-12. PubMed ID: 11874491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
    Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
    Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.
    Trisciuoglio D; Desideri M; Ciuffreda L; Mottolese M; Ribatti D; Vacca A; Del Rosso M; Marcocci L; Zupi G; Del Bufalo D
    J Cell Physiol; 2005 Dec; 205(3):414-21. PubMed ID: 15920759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
    Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
    Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.